Contract A207_PO-0448263-V3

The University of Virginia awarded a contract to Eurofins Genomics LLC on August 8, 2026, for the provision of synthetic oligonucleotide primers. The contract, identified as A207_PO-0448263-V3, is valued at twenty-four dollars and consists of five line items comprising salt-free, 25-base oligonucleotide sequences designed for molecular biology applications. The primers are designated for delivery to the buyer and include four variants of D121del primers (3-prime forward, 3-prime reverse, 5-prime forward, and 5-prime reverse) and one D121del sequencing primer, with quantities ranging from four to five units per line item.

Eurofins Genomics LLC, serving as the prime contractor, will supply these molecular biology reagents to support the University of Virginia's research or laboratory operations in Virginia. The contract represents a minimal-value purchase order, consistent with standard procurement processes for specialty research materials and supplies. No specific period of performance or place of performance distinct from the contracting organization's location has been identified in the available contract documentation.